造血
干细胞
免疫系统
造血干细胞移植
外周血干细胞
免疫学
移植
造血干细胞
效应器
生物
自然杀伤细胞
医学
细胞毒性T细胞
细胞生物学
内科学
体外
生物化学
出处
期刊:Cells
[MDPI AG]
日期:2022-11-02
卷期号:11 (21): 3469-3469
被引量:4
标识
DOI:10.3390/cells11213469
摘要
The infusion of autograft immune effector cells directly impacts the clinical outcomes of patients treated with autologous peripheral blood hematopoietic stem cell transplantation, suggesting the possibility of an autologous graft-versus tumor cells. Furthermore, the early recovery of immune effector cells also affects survival post-autologous peripheral blood hematopoietic stem cell transplantation. Natural killer cells are among the immune effector cells reported to be collected, infused, and recovered early post-autologous peripheral blood hematopoietic stem cell transplantation. In this review, I attempt to give an update on the role of natural killer cells regarding improving survival outcomes on patients treated with autologous peripheral blood hematopoietic stem cell transplantation.
科研通智能强力驱动
Strongly Powered by AbleSci AI